If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Adverse drug reactions (ADRs): a patient perspective on assessment and prevention in primary care

$20.00 plus tax (Refund Policy)

Buy Article:


A British Medical Association (BMA) report Reporting Adverse Drug Reactions, May 2006, estimated that 250 000 people a year are admitted to hospital suffering harmful effects of prescription drugs at a cost to the NHS of about £ 466 million a year. This is based on a 2004 study of hospital admissions. The BMA report draws attention to a crisis in public health that is largely being ignored and considers how medical education is failing both patients and doctors. The number of patients suffering and deaths due to adverse drug reactions (ADRs), addiction and withdrawal problems is underestimated, often unrecognised and not well reported. Ignoring the problem is costly in financial and human terms. The following paper describes the importance of the patient experience and recommends the need for systematic changes in practice and education of both the profession and the public in the recognition of ADRs. The paper includes recommendations for primary care trusts to be proactive in encouraging professional and patient Yellow Card ADR reporting, and to remind doctors of their moral duty to inform coroners of possible ADRs that may have preceded sudden death, suicide or fatal accidents. The paper concludes by emphasising the need for good practice in monitoring the side-effects of medicines, in order that patients gain the maximum benefits from their medicines


Document Type: Short Communication

Affiliations: Founder and Chair of Adverse Psychiatric Reactions Information Link (APRIL)

Publication date: August 1, 2007

More about this publication?
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more